, Tracking Stock Market Picks
Enter Symbol:

down 44.28 %


Posted on: Tuesday,  Aug 7, 2007  3:25 PM ET by Punk Ziegel & Co

Punk Ziegel & Co rated Buy LEXICON PHARMACEUTCL (NASDAQ: LXRX) on 08/07/2007, when the stock price was $21.77.
Since then, LEXICON PHARMACEUTCL has lost 44.28% as of 01/04/2016's recent price of $12.13.
If you would have followed this Punk Ziegel & Co's recommendation on LXRX, you would have lost 44.28% of your investment in 3072 days.

Lexicon Pharmaceuticals, Inc. (Lexicon), is a biopharmaceutical company focused on discovering and developing treatments for human disease. The Company uses its proprietary gene knockout technology to identify and develop new drugs. In its Genome5000 program, Lexicon is utilizing its knowledge of the function of nearly 5,000 genes to identify a portfolio of drug targets. Lexicon has advanced multiple drug candidates into human clinical trials and has a diverse pipeline of drug targets behind its clinical programs with many compounds and antibodies in preclinical research. Lexicon is conducting clinical trials for four drug candidates, with its most advanced program in Phase II clinical trials.

Our Research Department takes a fresh, critical approach to analyzing primary sources and developing proprietary research. Many individuals, institutions, portfolio managers and hedge fund managers, on all levels, have been neglected by brokerage firms ignoring the demands for unbiased research. Ladenburg Thalmann provides a superior branded in-depth research product geared only to action-oriented investment ideas. Ladenburg Thalmann’s proprietary equity research tries to uncover crucial information before the rest of the Street. Our analysts concentrate on uncovered and under-covered stocks and have a small to mid-cap focus. We will not shy away from large cap names as long as we can bring value to our clients through timely, differentiated ideas.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/7/2007 3:25 PM Buy
21.77 49.00
as of 8/27/2015
1 Week up  6.59 %
1 Month up  49.56 %
3 Months up  71.57 %
1 YTD down  -3.73 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy